Categories: News

CHOWIS to Develop Customized Cosmetics Diagnostic Platform in Partnership With Kolmar Korea

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Chowis Co. Ltd. Skin, Hair and Scalp Solutions Provider Signs Agreement with Kolmar Korea to Develop AI driven Skin Analysis Platform.

SEOUL, SOUTH KOREA / ACCESSWIRE / July 3, 2024 / Chowis Co. Ltd., a leading provider of AI skin diagnostic solutions in South Korea, has entered into a strategic partnership with Kolmar Korea to develop an advanced customized cosmetics diagnostic platform.

Chowis – Kolmar Korea
Chowis – Kolmar Korea

On May 29th, the collaboration was formalized through a Memorandum of Understanding (MOU) signed at Kolmar Korea’s R&D Complex in Naegok-dong, Seocho-gu, Seoul. The signing ceremony was attended by Han Sang-geun, Vice President of Korea Kolmar’s Technology Research Institute, and Ryan WS Choi, CEO of Chowis Co., Ltd.

Chowis Co., Ltd. is renowned for its mobile skin, hair, and scalp diagnostic solutions that leverage AI and LED optical technology. Their services include a web-based application that analyzes various skin conditions such as wrinkles, pigmentation, pores, and redness through full-face image captures.

The partnership aims to combine the technological expertise of both companies to develop a customized cosmetics diagnostic platform. Chowis Co., Ltd. will utilize its optical diagnostic technology to assess consumers’ skin conditions, while Kolmar Korea will interpret these analyses to recommend the optimal products tailored to individual skin profiles.

The diagnostic process will allow consumers to capture images of their faces via a beauty company’s website or app. The platform will analyze multiple skin conditions and incorporate a brief questionnaire about the consumers’ usual skin concerns and lifestyle habits. Based on this information, it will recommend personalized cosmetics. Should consumers decide to purchase the suggested products, Kolmar Korea will manufacture them. This initiative aims to support beauty companies in entering the customized cosmetics market by providing them with the diagnostic platform.

“We value promising collaborations such as this with Kolmar Korea. We share a common goal in providing accurate analysis and aligned recommendations to end consumers,” stated Ryan WS Choi, CEO of Chowis Co., Ltd.

Contact Information

Chowis Company
chowis@chowis.com

SOURCE: Chowis

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

1 hour ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

1 hour ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

1 hour ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

1 hour ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

1 hour ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

1 hour ago